Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | RHOA | P61586 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.53 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CBS | P35520 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29556844 | 1.00 | AKR1C3 (0.56) | AKR1C3MEN1KMT2ARHOANPC1 | |
| Hydrochloric Acid SCHEMBL4563542 | 0.98 | AKR1C3 (0.54) | AKR1C3MEN1KMT2ARHOANPC1 | |
| Isophthalic Acid SCHEMBL27617683 | 0.90 | TSHR (0.56) | AKR1C3MEN1KMT2ARHOAALDH1A1 | |
| SCHEMBL27843166 | 0.88 | KCNK3 (0.54) | AKR1C3MEN1KMT2ANPC1RAB9A | |
| SCHEMBL5151380 | 0.85 | NPSR1 (0.59) | MEN1KMT2AALDH1A1PKML3MBTL1 | |
| SCHEMBL19829331 | 0.84 | MEN1 (0.67) | MEN1KMT2APKML3MBTL1HPSE | |
| SCHEMBL9645083 | 0.84 | L3MBTL1 (0.63) | MEN1KMT2ARAB9AALDH1A1L3MBTL1 | |
| SCHEMBL13187424 | 0.84 | AKR1C3 (0.53) | AKR1C3MEN1KMT2ARHOANPC1 | |
| SCHEMBL30478066 | 0.83 | ALDH1A1 (0.66) | MEN1KMT2ANPC1RAB9AALDH1A1 | |
| SCHEMBL7768635 | 0.83 | ALDH1A1 (0.66) | MEN1KMT2ANPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110678450-B | Isoxazole derivatives as nuclear receptor agonists and uses thereof | 日东制药株式会社 | 2023-06-20 | — | — | CN | claimed |
| CN-116046493-A | Application of compound as matrix in mass spectrometry | 深圳湾实验室 | 2023-05-02 | — | — | CN | claimed |
| CN-115611814-A | Compound containing 2-aminoimidazole ring and preparation method and application thereof | 烟台新药创制山东省实验室 | 2023-01-17 | — | — | CN | claimed |
| CN-107109134-B | Use of Chemical Mechanical Polishing (CMP) compositions for polishing substrates comprising cobalt and/or cobalt alloys | 巴斯夫欧洲公司 | 2021-04-13 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| US-10385236-B2 | Use of a chemical mechanical polishing (CMP) composition for polishing of cobalt and / or cobalt alloy comprising substrates | BASF SE (DE) | 2019-08-20 | — | — | US | claimed |
| US-20180353607-A1 | LIPIDS FOR DELIVERY OF THERAPEUTICS | MARINA BIOTECH INC (US) | 2018-12-13 | — | — | US | claimed |
| EP-3237562-B1 | USE OF A CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION FOR POLISHING OF COBALT AND/OR COBALT ALLOY COMPRISING SUBSTRATES | BASF SE (DE) | 2018-09-26 | — | — | EP | claimed |
| US-20170362464-A1 | USE OF A CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION FOR POLISHING OF COBALT AND / OR COBALT ALLOY COMPRISING SUBSTRATES | BASF SE (DE) | 2017-12-21 | — | — | US | claimed |
| US-9821067-B2 | Lipopeptides for delivery of nucleic acids | MARINA BIOTECH, INC. (US) | 2017-11-21 | — | — | US | claimed |
| US-20100240731-A1 | LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS | MDRNA, INC. (US) | 2010-09-23 | — | — | US | claimed |
| EP-2197495-A2 | LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS | MDRNA, Inc. (US) | 2010-06-23 | — | — | EP | claimed |
| CN-101674853-A | Amino acid lipids and uses thereof | NASTECH PHARM CO | 2010-03-17 | — | — | CN | claimed |
| EP-2157982-A2 | AMINO ACID LIPIDS AND USES THEREOF | MDRNA, Inc. (US) | 2010-03-03 | — | — | EP | claimed |
| WO-2009046220-A2 | LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS | MDRNA, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-20080317839-A1 | AMINO ACID LIPIDS AND USES THEREOF | NASTECH PHARMACEUTICAL COMPANY INC. (US) | 2008-12-25 | — | — | US | claimed |
| WO-2008137758-A2 | AMINO ACID LIPIDS AND USES THEREOF | MDRNA, INC. (US) | 2008-11-13 | — | — | WO | claimed |
| EP-1884513-A1 | PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME | Japan Tobacco, Inc. (JP) | 2008-02-06 | — | — | EP | claimed |
| US-20070032529-A1 | Pyrazole compounds and their use as antidiabetes agents | JAPAN TOBACCO INC. (JP) | 2007-02-08 | — | — | US | claimed |
| US-5989845-A | Diagnostic compositions and devices utilizing same | MERCURY DIAGNOSTICS, INC. (US) | 1999-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080317839-A1 | AMINO ACID LIPIDS AND USES THEREOF | AADAT, AARS1, ABAT | AKR1C3 4626/4885MEN1 2512/4885KMT2A 1649/4885 |
| US-20100240731-A1 | LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS | LNPEP, LPXN, SLC27A1 | AKR1C3 4663/4885MEN1 2065/4885KMT2A 3714/4885 |
| US-20070032529-A1 | Pyrazole compounds and their use as antidiabetes agents | PYGL, GYS2, AGL | AKR1C3 173/4885MEN1 4075/4885KMT2A 4487/4885 |
| US-20180353607-A1 | LIPIDS FOR DELIVERY OF THERAPEUTICS | APOB, ABHD16A, LIPA | AKR1C3 4461/4885MEN1 2466/4885KMT2A 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.